Close Menu

NEW YORK (360Dx) – Vermillion said today its Aspira Labs subsidiary has entered into an agreement with Blue Cross Blue Shield of Louisiana for coverage of its OVA1 ovarian cancer test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.